The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Tanashyan M.M.

Research Center of Neurology

Maksimova M.Yu.

Research Center of Neurology

Oxidative stress and antioxidant protection in disorders of cerebral circulation

Authors:

Tanashyan M.M., Maksimova M.Yu.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12): 114‑119

DOI: 10.17116/jnevro2024124121114

Read: 1606 times

Download PDF (RU)
Contact the author
Table of contents

OXIDATIVE STRESS AND ANTIOXIDANT PROTECTION IN DISORDERS OF CEREBRAL CIRCULATION
OXIDATIVE STRESS AND ANTIOXIDANT PROTECTION IN DISORDERS OF CEREBRAL CIRCULATION

To cite this article:

Tanashyan MM, Maksimova MYu. Oxidative stress and antioxidant protection in disorders of cerebral circulation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12):114‑119. (In Russ.)
https://doi.org/10.17116/jnevro2024124121114

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Clinical and gene­tic asso­ciations in patients with non-cardioembolic ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):12-19
Biomarkers of athe­rothrombotic and cardioembolic subtypes of acute ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):20-26
Clinical and tomo­graphic comparisons in patients with apha­sia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):27-33
Neuroimaging predictors of hemo­rrhagic transformation of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):34-38
Neurocytoprotection adva­nces in repe­rfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88
Arte­rial hype­rtension is an oxidative stress, as a pathogenetic target for the treatment of chro­nic cere­brovascular insu­fficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):84-90
Sequential use of botu­linum toxin A and bovhyaluronidase azoximer in the correction of post-stroke spasticity. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):80-85
Central nervous system invo­lvement in systemic lupus erythematosus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):124-129
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Abstract:

At the present stage, great progress has been achieved in understanding the mechanisms of the development of cerebral ischemia. This became possible due to the achievements of theoretical disciplines, in connection with which the general biological approach was formed in the study of pathogenesis of acute and chronic cerebrovascular disorders (CVD). The discovery of pathways of free radical oxidation in cerebral ischemia made it possible to substantiate and develop therapeutic strategies using drugs with antioxidant and neuroprotective activity. The article presents our own data on the effectiveness of Mildronat in patients with CVD.

Keywords:

disorders of cerebral circulation
ischemic stroke
oxidative stress
antioxidant therapy
Mildronat

Authors:

Tanashyan M.M.

Research Center of Neurology

Maksimova M.Yu.

Research Center of Neurology

Received:

22.10.2024

Accepted:

28.10.2024

Close metadata

References:

  1. Stroke: modern technologies for diagnosis and treatment. Piradov MA, Tanashyan MM, Maksimova MYu, eds. 3rd ed. M.: MEDpress-inform; 2018. (In Russ.).
  2. Boldyrev AA. Oxidative stress and the brain. Soros Educational Journal. 2001; 7(4):21-28. (In Russ.).
  3. Kumar V, Bishayee K, Park S, et al.Oxidative stress in cerebrovascular disease and associated diseases. Front Endocrinol (Lausanne). 2023;14:1124419. https://doi.org/10.3389/fendo.2023.1124419
  4. D’Apolito E, Sisalli MJ, Tufano M, et al. Oxidative Metabolism in Brain Ischemia and Preconditioning: Two Sides of the Same Coin. Antioxidants (Basel). 2024;13(5):547.  https://doi.org/10.3390/antiox13050547
  5. Hosoki S, Hansra GK, Jayasena T, et al. Molecular biomarkers for vascular cognitive impairment and dementia. Nat Rev Neurol. 2023;19(12):737-753.  https://doi.org/10.1038/s41582-023-00884-1
  6. Gusev EI, Skvortsova VI. Ishemiya golovnogo mozga. M.: Meditsina; 2001. (In Russ.).
  7. Ludhiadch A, Sharma R, Muriki A, Munshi A. Role of Calcium Homeostasis in Ischemic Stroke: A Review. CNS Neurol Disord Drug Targets. 2022;21:52-61.  https://doi.org/10.2174/1871527320666210212141232
  8. Bano D, Nicotera P. Ca2+ signals and neuronal death in brain ischemia. Stroke. 2007;38(2 Suppl):674-676.  https://doi.org/10.1161/01.STR.0000256294.46009.29
  9. Lee JM, Grabb MC, Zipfel GJ, Choi D.W. Brain tissue responses to ischemia. J Clin Investig. 2000;106:723-731.  https://doi.org/10.1172/JCI11003
  10. Yang JL, Mukda S, Chen SD. Diverse roles of mitochondria in ischemic stroke. Redox Biol. 2018;16:263-275.  https://doi.org/10.1016/j.redox.2018.03.002
  11. Sommer C. Ischemic stroke: experimental models and reality. Acta Neuropathol. 2017;133(2):245-261.  https://doi.org/10.1007/s00401-017-1667-0
  12. Fedorova TN, Maksimova MYu, Varakin YuYa, et al. Oxidation of blood lipoproteins in patients with cerebrovascular diseases. Annals of Clinical and Experimental Neurology.2014;8(1):30-33. (In Russ.).
  13. Suslina ZA, Fedorova TN, Maksimova MYu, et al. Antioxidant therapy for ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2000; 100(10):34-38. (In Russ.).
  14. Piradov MA, Tanashyan M.M., Domashenko M.A, et al. Neuroprotection in cerebrovascular diseases: the search for life on Mars or a promising line of treatment? Part 1. Annals of Clinical and Experimental Neurology. 2015;9(1):41-50. (In Russ.).
  15. Piradov MA, Tanashyan MM, Domashenko MA, et al. Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 2. Chronic cerebrovascular diseases. Annals of Clinical and Experimental Neurology. 2015;9(3):10-19. (In Russ.).
  16. Dzerve VYa, Kalvinsh IYa. Mildronate in cardiology. Research Review. 2013. (In Russ.).
  17. Logina IP, Kalvinsh IYa. Mildronate in neurology. Research Review. 2012. (In Russ.).
  18. Maksimova M.Yu., Kistenev B.A., Domashenko M.A, et al. Clinical effectiveness and antioxidant activity of mildronate in ischemic stroke. Russian Journal of Cardiology. 2009;(4):55-63. (In Russ.).
  19. Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep. 2017;19(11):42.  https://doi.org/10.1007/s11883-017-0678-6
  20. Chen D, Zhang T, Lee TH. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. Biomolecules. 2020;10:1158. https://doi.org/10.3390/biom10081158
  21. Zhao Y, Zhang X, Chen X, Wei Y. Neuronal Injuries in Cerebral Infarction and Ischemic Stroke: From Mechanisms to Treatment (Review). Int J Mol Med. 2022;49:15.  https://doi.org/10.3892/ijmm.2021.5070
  22. Casado A, Encarnación López-Fernández M, Concepción Casado M, de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res. 2008;33(3):450-458.  https://doi.org/10.1007/s11064-007-9453-3
  23. Trujillo-Rangel WÁ, García-Valdés L, Méndez-Del Villar M, et al. Therapeutic Targets for Regulating Oxidative Damage Induced by Ischemia-Reperfusion Injury: A Study from a Pharmacological Perspective. Oxid Med Cell Longev. 2022;2022:8624318. https://doi.org/10.1155/2022/8624318
  24. Bennett S, Grant M, Aldred S. Oxidative Stress in Vascular Dementia and Alzheimer’s Disease: A Common Pathology. J Alzheimer’s Dis. 2009;17:245-257.  https://doi.org/10.3233/JAD-2009-1041
  25. Luca M, Luca A, Calandra C. The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer’s Disease and Vascular Dementia. Oxid Med Cell Longev. 2015;2015:504678. https://doi.org/10.1155/2015/504678
  26. Shishkova VN, Remennik AI, Kerimova EI. Current opportunities for improving recovery potential in elderly patients after ischemic stroke. Consilium Medicum. 2019;21(9):24-28. (In Russ.).
  27. Tanashyan MM, Maksimova MYu, Shabalina AA, et al.Chronic cerebrovascular diseases and neuroprotection: the clinical efficacy of meldonium (Mildronat). S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(10):14-21. (In Russ.). https://doi.org/10.17116/jnevro202012010114
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.